AnalystsEdwin ZhangEdwin Zhang's Stock Forecasts
AnalystsEdwin Zhang
Sectors:
Industries:
Analyst Ranking
Bottom 10%
#4158 out of 4577 analysts
Average Return
-26.46%
Win Rate
40%4 out of 10
Risk vs Reward
Poor
Good
Edwin Zhang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Enliven Therapeutics IncELVN | +26.33% | $13.52 | $17.08 | 2021-11-29 - 2022-11-29 | Buy |
Calliditas Therapeutics AbCALT | +20.98% | $17.06 | $20.64 | 2023-10-15 - 2024-05-07 | Buy |
Calliditas Therapeutics AbCALT | +18.35% | $17.44 | $20.64 | 2023-08-20 - 2024-05-07 | Buy |
Calliditas Therapeutics AbCALT | +13.41% | $18.20 | $20.64 | 2023-06-19 - 2024-05-07 | Buy |
Edwin Zhang Analyst Color
Get additional color on Edwin Zhang's coverage of popular stocks
Edwin Zhang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Calliditas Therapeutics AbCALT | 4 | Buy | $50.00 | +142.25% | Reiterates | 7 months ago |
Reneo Pharmaceuticals IncRPHM | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
Enliven Therapeutics IncELVN | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $106.00 | N/A | Initiates Coverage On | 3 years ago |
Logicbio Therapeutics IncLOGC | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Fibrogen IncFGEN | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Liminal Biosciences IncLMNL | 1 | Buy | $110.00 | N/A | Initiates Coverage On | 3 years ago |
Aldeyra Therapeutics IncALDX | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.